Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
RESCAP by Alloksys Life Sciences for Burns: Likelihood of Approval
RESCAP is under clinical development by Alloksys Life Sciences and currently in Phase II for Burns. According to GlobalData, Phase...
Data Insights
RESCAP by Alloksys Life Sciences for Acute Renal Failure (ARF) (Acute Kidney Injury): Likelihood of Approval
RESCAP is under clinical development by Alloksys Life Sciences and currently in Phase III for Acute Renal Failure (ARF) (Acute...